At Evotec, we empower your oncology and immuno-oncology programs with high-quality, ethically conducted in vivo studies that deliver actionable insights - from early discovery to translational success. Our state-of-the-art AAALAC-accredited facilities, combined with deep disease expertise and advanced analytics, provide a robust platform to evaluate efficacy, pharmacodynamics, and safety across a range of therapeutic modalities.

Whether you're validating targets, exploring novel mechanisms, or optimizing drug candidates, our tailored in vivo solutions integrate seamlessly into your discovery pipeline. Explore how our comprehensive suite of syngeneic, xenograft, humanized, and PDX models - supported by cutting-edge technologies and expert teams - can help drive your oncology innovations forward